| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.029 | 0.9 |